The K@W Network:
While pharmaceutical companies hope their television ads might convince a consumer to choose their drug over a rival’s, new Wharton research finds that the ads have a number of additional,[…]
The Supreme Court ruling on health care subsidies has averted disruption of the market, but more states may tap the federal marketplace, say experts.
Are the FDA's medical device regulations too hard, too soft, or just right? Wharton research indicates that the agency is on the right track.
The new health care landscape is fueling consolidation for hospitals, physicians groups -- and now insurers. So who are the winners and losers?
To get medical care to patients in Africa, it takes vehicles -- a lot of them. Nonprofit Riders for Health has the mission of managing those vehicles and keeping them[…]
In the American workplace, many a stigma has fallen. Mental illness, though, has notably lagged -- and employees and companies are both paying the price.
New Wharton research finds that smokers are more likely to quit if their own money is at stake. The bigger challenge, however, may be figuring out how to structure an[…]
In the last hospital merger wave in the 1990s, things did not go so well. Today, a new consolidation scramble is underway. Will this time be different?
As McDonald’s promises chicken free of human antibiotics, it wins on both food safety and marketing strategy. Experts discuss the gains -- and challenges -- for the company.
Some thought Obamacare would mean the end of employment-based insurance. While that did not happen, the threat has not fully lifted, according to Wharton’s Mark Pauly.